RNU7-12P

Across TCGA pan-cancer cohorts, RNU7-12P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNU7-12P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RNU7-12P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU7-12P is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

STAD, BLCA, and COAD are the cancer types where RNU7-12P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU7-12P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	All	+0.814	<.001	6	view →
BLCA	All	All	+0.521	.009	5	view →
COAD	All	II,III,IV	−0.112	.042	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RNU7-12P–STAD

Open the STAD breakdown →